🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma B-Cell › Texas › San Antonio

Qorannoo klinikaalii Lymphoma B-Cell San Antonio, TX keessatti

Qorannoo 6 Lymphoma B-Cell f San Antonio fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Namoota walitti qabaa jiraSadarkaa 1
  • Methodist Children's Hospital, San Antonio
Umuriin 0 hanga 18 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06173518

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, San Antonio
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06526793

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Transplant Institute, San Antonio
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Transplant Institute, San Antonio
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Texas Transplant Institute, San Antonio
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • SCRI, San Antonio
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT05643742

Qorannoo Lymphoma B-Cell magaalota biroo keessatti

Qorannoo biroo San Antonio keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.